Abstract
The first reports on structure and chemotherapeutic potential of two ‘red pigments’ belonging to the anthracycline class of natural products, daunorubicin and doxorubicin, were published 20 years ago. Since then many other anthracyclines have been studied, but it was only the discovery of the potent antineoplastic activity of doxorubicin and its subsequent fast approval in 1974 by the U.S. Federal Drug Administration (FDA) as a prescription drug which triggered off the attention of the scientific community. The search for other anthracycline analogues with better therapeutic indices than doxorubicin has been tenaciously pursued in many laboratories around the world. The therapeutic efficacy of doxorubicin was limited by toxic side effects, mainly cardiotoxicity and myelosuppression. The research efforts have brought the discovery of other clinically useful anthracyclines, such as aclacinomycin A and carminomycin, isolated from natural sources, and the discovery, in synthetic laboratories, that minor structural changes in the lead compound doxorubicin might significantly improve the therapeutic index.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References and notes
F. Arcamone, ‘Doxorubicin’, in Medicinal Chemistry, Vol. 17, Academic Press, New York (1981).
A. Grein, C. Spalla, A. Di Marco and G. Canevazzi, G. Microbiol. 11 (1983) 109.
M. Dubost, P. Ganter, R. Maral, L. Ninet, S. Pinneret, J. Preud’Homme and G.H. Werner, C.R. Acad. Sci. 257 (1963) 1813.
F. Arcamone, G. Cassinelli, G. Franceschi, P. Orezzi and S. Penco, Gazz. Chim. Ital. 100 (1970) 949.
A. Di Marco, M. Gaetani, L. Dorigotti, M. Soldati and O. Bellini, Tumori 49 (1963) 203.
F. Arcamone, G. Cassinelli, G. Fantini, A. Grein, P. Orezzi, C. Pol and C. Spalla, Biotechnol. Bioeng. 11 (1969) 1101.
R. B. Weiss, G. Sarosy, K. Clagett-Carr, M. Russo and B. Leyland-Jones, Cancer Chemother. Pharmacol. 18 (1986) 185.
M. D. Green, J. L. Speyer and F. M. Muggia, Eur. J. Cancer Clin. Oncol. 20 (1984) 293
D. H. Von Hoff, M. W. Layard, P. Basa, H. L. Davis Jr., A. L. Von Hoff, N. Rozencweig and F. M. Muggia, Ann. Intern. Med. 91 (1979) 710.
M. B. Naff, J. Plowman and V. L. Narayanan, in Anthracycline Antibiotics, ed. H.S. El Kadem, Academic Press, New York (1982).
F. Arcamone, Cancer Res. 45 (1985) 5995.
F. M. Muggia, C. W. Young and S. K. Carter (eds.), Anthracycline Antibiotics in Cancer Therapy, Martinus Nijhoff, The Hague (1982).
M. G. Brazknikova, V. B. Zbarskiy, M. K. Kudinova, L. I. Murav’yeva, V. I. Potomarenko and N. P. Potopova, Antibiotiki (Moskow) 18 (1973) 678
L. H. Baker, D. H. Kessel, R. L. Lamis, S. D. Reich, M. D. De Furia and S. T. Crooke, Cancer Treat. Rep. 63 (1979) 899.
F. Arcamone, L. Bernardi, B. Patelli, A. Di Marco, A. M. Casazza, G. Pratesi and P. Reggiani, Cancer Treat. Rep. 60 (1976) 829.
G. L. Tong, D. W. Henry and E. M. Acton, J. Med. Chem. 22 (1979) 36.
F. Arcamone, S. Penco, A. Vigevani, S. Redaelli, G. Franchi, A. Di Marco, A. M. Casazza, T. Dasdia, F. Formelli, A. Necco and C. Soranzo, J. Med. Chem. 18 (1975) 703
A. Suarato, S. Penco, A. Vigevani and F. Arcamone, Carbohydr. Res. 98 (1981) C1.
F. Arcamone, S. Penco, S. Redaelli and S. Hanessian, J. Med. Chem. 19 (1976) 1424
S. Penco, F. Arcamone and A. Di Marco, U. S. Patent 4, 067, 969 (January 10, 1978)
16.(c) A. Suarato, S. Penco and F. Arcamone, British Patent Appl, 8031382 (September 29,1980)
F. Arcamone, Adv. Med. Oncol. Res. Educ. 5 (1979) 21.
A. Suarato, S. Penco, F. Arcamone and A. M. Casazza, U. S. Patent 4, 438, 105 (March 20, 1984).
H. Umezawa, Y. Takahashi, M. Kinoshita, H. Naganawa, T. Masuda, M. Ishizuka, K. Tatsuta and T. Takeuchi, J. Antibiot. 32 (1979) 1082.
E. M. Acton, G. L. Tong and C. W. Mosher, J. Med. Chem. 27 (1984) 638
E. M. Acton, G. L. Tong, D. L. Taylor, J. A. Filppi and R. L. Walgemuth, J. Med. Chem. 29 (1986) 1225.
20.(a) G. Jolles, Ger. Patent 1,803, 892 (May 29,1969) (Chem. Abstracts 71 (1969) 7090;(b) R. K. Johnson, A. A. Ovejera and A. Goldin, Cancer Treat. Rep. 60 (1976) 99; (c) R. Maral, Cancer Chemother. Pharmacol. 2 (1979) 31.
R. Maral, J. B. Ducer, D. Farge, G. Rousinet and D. Reisdorf, C.R. Acad. Sci. Paris (D) 286 (1978) 443.
M. Israel and E. J. Modest, U. S. Patent 4,035, 566 (1977)
L. M. Parker, M. Hirst and M. Israel, Cancer Treat. Rep. 62 (1978) 119
R. H. Blum, M. B. Garntiick, M. Israel, G. P. Canellas, I. C. Henderson and E. Frei III, Cancer Treat. Rep. 63 (1979) 919
M. Israel and G. Patti, J. Med. Chem. 25 (1982) 187.
T. Oki, Y. Matsuzawa, A. Yashimoto, K. Numata, I. Kitamura, S. Hori, A. Takamatsu, H. Umezawa, M. Ishizuka, H. Naganawa, H. Suda, M. Hamada and T. Takeuchi, J. Antibiot. 28 (1975) 830.
D. E. Nettleton Jr., T. W. Doyle and W. T. Bradner, U. S. Patent 4,123,608 (Oct. 31,1978)
W. T. Bradner and M. Misiek, J. Antibiot. 30 (1977) 519.
25.(a) L. D. Zelezmick and C.M. Sweeney, Arch. Biochem. Biophys. 120 (1967) 292;(b) P. F. Wiley, F. A. Mac Keller, E. L. Caron and R. B. Kelly, Tetrahedron Lett. (1968) 663;(c) P. F. Wiley, R. B. Kelly, E. L. Caron, V. H. Wiley, J. H. Johnson, F. A. Mac Keller and S. A. Mizsak, J. Am. Chem. Soc. 99 (1972) 542.
26.(a) P. F. Wiley, J. H. Johnson and D. J. Hauser, J. Antibiot. 30 (1977) 628;(b) G. L. Neil, C. L. Blowers, D. J. Houser, J. H. Johnson and P. F. Wiley, Proc. Am. Assoc. Cancer Res. 18 (1977)
R.B. Weiss and S. Bruno, Cancer Treat. Rep. 65 (Suppl. 4) (1981) 25.
F. Arcamone, G. Franceschi and S. Penco, U. S. Patent 3, 803, 124 (April 9, 1974).
A. Vigevani, M. J. Williamson, Doxorubicin, Analytical Profdes of Drug Substances, Vol. 9, ed. K. Florey, Academic Press, New York (1980).
Due to the decomposition, the melting temperature is affected by heating rate.
Determined in methanol (0.1%) at 589 nm using a Perkin-Elmer Model 241 MC polarimeter.
Titration of an aqueous solution of the compound with N/20 sodium hydroxide. Solutions of anthracycline show indicator-like properties, turning from orange-red to blue-violet about pH 9.
Partition coefficient between 1-octanol and Tris buffer (pH 7) with constant ionic strength (I = 0.1) at room temperature after shaking for 15 h.
F. Arcamone, G. Cassinelli, S. Penco, G. P. Vicario and A. Vigevani, in Epirubicin, ed. G. Bonadonna, Masson (Milan) (1984) pp. 3–28.
F. Ganzina, Cancer Treat. Rev. 10 (1983) 1.
F. Ganzina, N. Di Pietro and O. Magni, Tumori 71 (1985) 233.
P. Deesen and B. Leyland-Jones, Drug Metab. Dispos. 12 (1984) 9
G. Cassinelli, E. Configliacchi, S. Penco, G. Rivola, F. Arcamone, A. Pacciarini and L. Ferrari, Drug Metab. Dispos. 12 (1984) 506.
F. Ganzina, M. A. Pacciarini and N. Di Pietro, Invest. New Drugs 4 (1986) 85.
A. DiMarco, A. M. Casazza and G. Pratesi, Cancer Treat Rep. 61 (1977) 893
F. Pannuti, C. M. Camaggi, E. Stropcchi, R. Comparsi, B. Angelelli and M. A. Pacciarini, Cancer Chemother. Pharmacol. 16 (1986) 295.
40.(a) E. Moro, V. Bellotti, M. G. Jannuzzo, S. Stegnjich and G. Valzelli, J. Chromatogr. Biomed Appl. 274 (1983) 281;(b) T. Bordoni, B. Barbieri, C. Geroni, G. Cassinelli, M. Grandi and F. C. Giuliani, 7th Int. Symp. on Future Trends in Chemotherapy, Tirrenia, Italy, Abst. 107 (1986).
(a) R. J. Stoodley, The anthracycline antibiotics: some synthetic endeavours, Second SCI-RSC Medicinal Chemistry Symposium (1984) pp. 134-147; (b) M. Suzuki, T. Matsumoto, R. Abe, Y. Kimura and S. Terashima, Chem. Lett. (1985)57; (c) M. J. Broadhurst, C. H. Hassal and G. J. Thomas, Chem. Ind. (London) (1985) 106.
C. M. Wong, D. Popien, R. Schwenk and T. Raa, Can. J. Chem. 49 (1971) 2712.
(a) M. Suzuki, Y. Kimura and S. Terashima, Chem. Lett. (1985) 367; (b) M. Sodeoka, T. Iimori and M. Shibosaki, Tetrahedron Lett. (1985) 6497.
F. Arcamone, Topics in Antibiotics Chemistry, Vol. 2, ed. P. Sammes, Ellis Harwood, Chichester (1978) pp. 102–239.
F. Arcamone, G. Franceschi, S. Penco and A. Selva, Tetrahedron Lett. (1969) 1007.
L. Dusonchet, N. Gebbia and F. Gerbassi, Pharmacol. Res. Commun. 3 (1971) 55.
H. Brockman, H. Brockman Jr. and J. Niemeyer, Tetrahedron Lett. (1968) 4719.
A. Suarato, unpublished results.
J. Jolles and G. Ponsinet, Ger. Patent 2, 206, 690 (July 27, 1972).
F. Arcamone, L. Bernardi, B. Patelli and A. Di Marco, Ger. Patent 2, 557, 537 (July 8,1976).
F. Arcamone, L. Bernardi and B. Patelli, Ger. Patent 2, 713, 745 (Oct. 13, 1977).
52.(a) T. H. Smith, A. N. Fujiwara and D. W. Henry, Am. Chem. Soc. 172nd Meet. Abstr. Medi (1976) 88
T. H. Smith, A. N. Fujiwara and D. H. Henry J. Med. Chem. 21 (1978) 280.
S. Penco, G. Franchi and F. Arcamone, Belg. Patent, 876, 100 (Nov. 8, 1979).
S. Penco, F. Angelucci, A. Vigevani, E. Arlandini and F. Arcamone, J. Antibiot. 30 (1977) 764.
S. Penco, F. Angelucci, F. Gozzi, G. Franchi, B. Gioia, A. Vigevani and F. Arcamone, Int. Symp. Chem. Nat. Prod, 11th Golden Sands Bulg, 4, Part 1, 448 (1978).
T. H. Smith, A. N. Fujiwara and D. W. Henry, J. Med. Chem. 22 (1979) 40.
D. W. Wilson, D. Grier, R. Reimer, J. D. Bauman, J. F. Preston and E. J. Grabbay, J. Med. Chem. 19 (1976) 381.
S. Penco, G. Franchi and F. Arcamone, Ger. Patent 2, 751, 395 (May 18, 1978).
A. Surato, S. Penco and M. Caruso, G. B. Pat. 2, 159, 518A (December 4, 1985).
A. Bargiotti, M. Caruso, A. Suarato, S. Penco and F. Giuliani, E. Patent 199 920 (December 10, 1986).
D. W. Henry and G. L. Tong, U. S. Patent 4, 112, 217 (September 5, 1978).
G. P. Vicario, S. Penco and F. Arcamone, U. S. Patent 4, 211, 864 (July 8, 1980)
S. Penco, G. P. Vicario, F. Angelucci and F. Arcamone, J. Antibiot. 30 (1977) 773.
E. M. Acton and G. L. Tong, J. Med. Chem. 24 (1981) 669.
P. K. Chakravarty, C. L. Philip, W. J. Michael and J. A. Katzenellenbogen, J. Med. Chem. 26 (1983) 638.
B. R. Vishnuvajjala, T. Kataoka, F. D. Cazer, D. T. Witiak, and L. Malspeis, J. Labelled Compd. Radiopharm. 14 (1978) 111.
C. R. Chen, M. Tan Fong, A. N. Fujiwara, D. W. Henry, M. A. Leafer, W. W. Lee and T. H. Smith, Cancer Res. 35 (1975) 1175.
J. J. Langone, H. van Vunakis, N. Bachur, Biochem. Med. 12 (1975) 283.
M. Israel, W. J. Pegg, P. M. Wilkinson and M. B. Garnick, J. Liquid Chromatogr. 1 (1978) 795.
R. Hulhoven and J. O. Desager, J. Chromatogr. 125 (1976) 369.
R. B. Weenen, J. M. S. Van Maanen and M. M. Planque, Eur. J. Cancer Clin. Oncol. 29 (1984) 919.
M. Broggini and T. Colombo, Cancer Treat. Rep. 68 (1984) 739.
S. Penco, G. Cassinelli, A. Vigevani, P. Zini, G. Rivola and F. Arcamone, Gazz. Chim. Ital. 115 (1985) 195.
T. Oki, Y. Matsuzawa, A. Yoshimoto, K. Numata, I. Kitamura, S. Hori, A. Takamatsu, H. Umezawa, M. Ishizuka, H. Naganawa, H. Suda, M. Hamada and T. Takeuchi, J. Antibiot. 28 (1975) 830
T. Oki, N. Shibamoto, Y. Matsuzawa, T. Ogasawara, A. Yashimoto, I. Kitamura, T. Inui, H. Naganawa, T. Takeuchi and H. Umezawa, J. Antibiot. 30 (1987) 683.
T. Oki, I. Kitamura, Y. Matsuzawa, N. Shibamoto, T. Ogasawara, A. Yoshimoto, T. Inui, H. Naganawa, T. Takeuchi and H. Umezawa, J. Antibiot. 32 (1979) 801.
H. Brockman, E. Spohler and T. Waehnelt, Chem. Ber. 96 (1963) 2925.
B. Iselin and T. Reichstein Helv. Chim. Acta 21 (1944) 1200.
Keller-Schielein and W. W. Richie Chimia 24 (1970) 35.
J. J. Gordon, Tetrahedron Lett. 8 (1960) 28
H. Brockmann, Jr., H. H. Budzikewicz, C. Djerssi, H. Brockmann and J. Niemeyer, Chem. Ber. 98 (1965) 1260.
S. T. Crooke, V. H. Duvernay and L. Galvan, Mol. Pharmacol. 14 (1978) 290.
T. Oki, T. Takeuchi, S. Oka and H. Umezawa, in Recent Results in Cancer Research, eds. G. Mathe and F.M. Muggia, Springer-Verlag, Berlin, 74 (1980) 207
T. Oki, T. Takeuchi, S. Oka and H. Umezawa, in Recent Results in Cancer Research, eds. S.K. Carter, Y. Sakurai and H. Umezawa, Springer-Verlag, Berlin 76 (1981) 21
T. Kubota, Y. Shimosato and Y. Hwa, Jpn. J. Cancer Chemother. 5 (1978) 55.
S. Fujimoto, J. Inagati, N. Horikoshi and M. Ogawa, Gann 70 (1979) 411.
D. Dantchev, V. Slioussartchouk and M. Paintrad, Cancer Treat. Rep. 63 (1979) 875.
H. Furue, T. Komita and I. Nakao, in Recent Results in Cancer Research, eds. S.K. Carter, H. Umezawa, J. Douras and Y. Sakurai, Springer-Verlag, Berlin, 63 (1978).
K. Yamada, Jpn. J. Cancer Chemother. 10 (Part II) (1983) 1030
K. Yamada, T. Nakamura, T. Tsuruo et al, Cancer Treat. Rev. 1 (1980) 177.
H. Suzuki, K. Kawashima and K. Yamada, Lancet (1979) 870.
T. Oki, I. Kitamura, Y. Matsuzawa, N. Shibamoto, T. Ogasawara, A. Yoshimoto, T. Inui, H. Naganawa, T. Takeuchi and H. Umezawa, J. Antibiot. 32 (1979) 791.
B. Gioia, E. Arlandini and A. Vigevani, Biomed. Mass Spectrom. 11 (1984) 35.
T. Kamijana, T. Oki, T. Inui, T. Takeuchi and H. Umezawa, Biochem. Biophys. Res. Commun. 82 (1978) 188.
T. Komiyane, T. Oki and T. Inui, J. Antibiot. 32 (1979) 1219
T. Ogasawara, Y. Masuda, S. Goto, S. Mari and T. Oki J. Antibiot. 34 (1981) 52.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Blackie & Son Ltd
About this chapter
Cite this chapter
Suarato, A. (1990). Antitumour anthracyclines. In: Wilman, D.E.V. (eds) The Chemistry of Antitumour Agents. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-0397-5_2
Download citation
DOI: https://doi.org/10.1007/978-94-009-0397-5_2
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-6665-5
Online ISBN: 978-94-009-0397-5
eBook Packages: Springer Book Archive